We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
These draft regulations set out the additional conditions that expenditure by employers on recommended medical treatment must meet in order to qualify for the tax exemption at section 12 of Finance Act 2014.
Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Wet line contamination involves the cross contamination of road fuel with rebated fuels, which will either be red diesel or kerosene.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Answers to frequently asked questions on Approved Document B including 2020 and 2022 amendments.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
How to package medicines for sale and what information you must provide to consumers and healthcare professionals.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
How to use a cost benefit analysis to evaluate your digital health product.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Share your reference data for use in projects and services outside your organisation.
This document explains the NHS view on private screening for different conditions and diseases.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
How to use a before-and-after study to evaluate your digital health product.
What best available techniques are, when you must follow them, how to propose alternatives and how to refer to them in your application.
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).